# Season Venture Capital

> Season Venture Capital is a VC fund backing Medical, Pharmaceutical and Biopharma. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: May 2023
- Lead investor: 33%
- Last updated: Aug 2026

Season Venture Capital is a venture capital firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 67% |
| Pharmaceutical | 2 | 67% |
| Biopharma | 1 | 33% |
| Biotechnology | 1 | 33% |
| Medical Device | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Angel | 1 | 33% |
| Series A | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Taichu Biotechnology | Taichu Biotechnology offers customized CRO+CDMO technical services for single and combined business sectors for the development and manufacturing of various novel pharmaceuticals. |  | Series A | May 08, 2023 |  |
| Puji Bio | Puji Bio is a medical firm that develops molecular diagnostic kits and instruments for tumor diagnosis, birth defect screening, etc. | $15.7M | Angel | Jan 10, 2022 |  |
| Tripod Preclinical Research Laboratories | Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), foodadditives, biologics，pesticides，veterinary drugs, and new cosmetics. | $156.3M | Venture - Series Unknown | Nov 05, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 2 deals together
- [Vertex Ventures China](https://shizune.co/investors/profile/vertex-ventures-china) — VC Fund, 2 deals together
- [3H Health Investment](https://shizune.co/investors/profile/3h-health-investment) — VC Fund, 1 deal together
- [Aopeng Investment](https://shizune.co/investors/profile/aopeng-investment) — VC Fund, 1 deal together
- [Apricot Capital](https://shizune.co/investors/profile/apricot-capital-ceb8) — VC Fund, 1 deal together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [LVX Ventures](https://shizune.co/investors/profile/letsventure) — VC Fund
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund
- [IAN Group](https://shizune.co/investors/profile/indian-angel-network) — VC Fund

## FAQ

### What does Season Venture Capital invest in?

Season Venture Capital invests primarily in Medical, Pharmaceutical and Biopharma startups, most often at Angel and Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Season Venture Capital last invest?

The most recent investment recorded for Season Venture Capital closed in May 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co